The FY2024 (Dec) proxy of PTC Therapeutics names 16 peer companies for pay. Among PTC Therapeutics and these peers, CEO pay was the lowest of 9 and total shareholder return was 6th highest of 9.
9th highest of 9in PTC Therapeutics and its pay peers, FY2024 (Dec) by CEO pay:
$7.4M$17.8M
6th highest of 9in PTC Therapeutics and its pay peers, FY2024 (Dec) by total shareholder return:
$43$289
Pay peer group, FY2024 (Dec) proxy
| Supernus Pharmaceuticals | ||
| Jazz Pharmaceuticals | ||
| Ionis Pharmaceuticals | ||
| Ultragenyx Pharmaceutical | ||
| Halozyme Therapeutics | ||
| INSMED | ||
| Alkermes plc. | ||
| Acadia Pharmaceuticals | ||
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Apellis Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Blueprint Medicines Corp. | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Exelixis | Not disclosed | Not disclosed |
| Intra-Cellular Therapies, Inc. | Not disclosed | Not disclosed |
| Pacira BioSciences, Inc. | Not disclosed | Not disclosed |
| Sarepta Therapeutics, Inc. | Not disclosed | Not disclosed |
16 companies
Changes by year
FY2025 (Dec) proxy
- AddedAxsome Therapeuticspay peer group
- AddedHarmony Biosciences Holdings, Inc.pay peer group
- AddedMadrigal Pharmaceuticalspay peer group
FY2024 (Dec) proxy
- AddedCorcept Therapeuticspay peer group
- AddedHalozyme Therapeuticspay peer group
- RemovedFibrogen, Inc.pay peer groupbecause each company’s market cap, combined with other metrics, such as employee headcount and revenue, were no longer in the intended range
- RemovedNeurocrine Biosciencespay peer groupbecause each company’s market cap, combined with other metrics, such as employee headcount and revenue, were no longer in the intended range
FY2023 (Dec) proxy
- RemovedAgios Pharmaceuticalspay peer groupbecause each company’s market cap, combined with other metrics, such as employee headcount and revenue, were no longer in the intended range
- RemovedGlobal Blood Therapeutics, Inc.pay peer groupbecause it was acquired in 2022
- RemovedIronwood Pharmaceuticals, Inc.pay peer groupbecause each company’s market cap, combined with other metrics, such as employee headcount and revenue, were no longer in the intended range
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.